These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 19853027

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Extruded and spheronized beads containing no microcrystalline cellulose: influence of formulation and process variables.
    Agrawal AM, Howard MA, Neau SH.
    Pharm Dev Technol; 2004; 9(2):197-217. PubMed ID: 15202579
    [Abstract] [Full Text] [Related]

  • 3. Use of extrusion aids for successful production of Kollidon® CL-SF pellets by extrusion-spheronization.
    Loka NC, Saripella KK, Pinto CA, Neau SH.
    Drug Dev Ind Pharm; 2018 Apr; 44(4):632-642. PubMed ID: 29183166
    [Abstract] [Full Text] [Related]

  • 4. Use of fine particle ethylcellulose as the diluent in the production of pellets by extrusion-spheronization.
    Mallipeddi R, Saripella KK, Neau SH.
    Saudi Pharm J; 2014 Sep; 22(4):360-72. PubMed ID: 25161381
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV, Gu L, Soh JL, Heng PW.
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Analysis of particle kinematics in spheronization via particle image velocimetry.
    Koester M, Thommes M.
    Eur J Pharm Biopharm; 2013 Feb; 83(2):307-14. PubMed ID: 23000404
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Formulation and characterization of a compacted multiparticulate system for modified release of water-soluble drugs--Part II theophylline and cimetidine.
    Cantor SL, Hoag SW, Augsburger LL.
    Drug Dev Ind Pharm; 2009 May; 35(5):568-82. PubMed ID: 18979306
    [Abstract] [Full Text] [Related]

  • 15. Manufacture of fine spherical granules by an extrusion/spheronization method.
    Kanbe H, Hayashi T, Onuki Y, Sonobe T.
    Int J Pharm; 2007 Jun 07; 337(1-2):56-62. PubMed ID: 17257789
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An investigation into the effect of formulation variables and process parameters on characteristics of granules obtained by in situ fluidized hot melt granulation.
    Mašić I, Ilić I, Dreu R, Ibrić S, Parojčić J, Durić Z.
    Int J Pharm; 2012 Feb 28; 423(2):202-12. PubMed ID: 22197773
    [Abstract] [Full Text] [Related]

  • 20. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY, Yap HN, Chaw CS.
    Drug Dev Ind Pharm; 2014 Mar 28; 40(3):418-24. PubMed ID: 23480532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.